Product Information
ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) is a generic product labeled by Fresenius Kabi USA, LLC, priced at $1.3184 per ML under NDC 63323069210. Its NADAC has been published 156 times since Jun 22, 2016.
FDA first approved this application on Jun 21, 2012. Its Orange Book therapeutic-equivalence code is AN.
Strength
200 mg/mL
Manufacturer
Fresenius Kabi USA, LLCNDC
63323069210
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL; RESPIRATORY (INHALATION)
Effective Date
4/23/2025
Active Ingredients
ACETYLCYSTEINEApproval Type
Generic (ANDA)
FDA Application
ANDA203853FDA Approved
6/21/2012
TE Code
AN
On Market Since
9/1/2012
Pharmacological Classes
Price Statistics
The NADAC for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) has been published 156 times since Jun 22, 2016, and over the history we have for it it has risen 14.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.3184 per ML |
|---|---|
| All-time high | $1.3414 (Nov 13, 2024) |
| All-time low | $1.1541 (Jun 22, 2016) |
| 52-week high | $1.3184 |
| 52-week low | $1.3184 |
| Median price | $1.3173 |
| Average price | $1.2598 |
| Largest weekly change | +12.9% (Aug 21, 2024) |
| Weeks tracked | 156 |
| Tracking since | Jun 22, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
0.0%
1Y
0.0%
3Y
+11.0%
5Y
+11.0%
All
+14.2%
Last surveyed Apr 15, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 44% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)?
The current National Average Drug Acquisition Cost (NADAC) for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION), manufactured by Fresenius Kabi USA, LLC, is $1.3184 per ML (NDC 63323069210), effective Apr 15, 2026.
How has the price of ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) changed over time?
Over the history we have for it, the NADAC for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) has risen 14.2%. It has been tracked across 156 weekly CMS publications since Jun 22, 2016.
What are the highest and lowest recorded NADAC prices for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)?
Since Jun 22, 2016, the NADAC for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) has ranged from a low of $1.1541 (Jun 22, 2016) to a high of $1.3414 (Nov 13, 2024), with a median of $1.3173 per ML.
Are there cheaper alternatives to ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION), is $0.7413 per ML — about 44% below ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION).
Who manufactures ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)?
ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) (NDC 63323069210) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.